TPG:NASDAQTPG Inc. Analysis
Data as of 2026-05-05 - not real-time
$45.82
Latest Price
8/10Risk
Risk Level: High
Executive Summary
TPG Inc. trades at a trailing P/E of 99.6×, far above the asset‑management industry average of 17.5×, while its forward P/E contracts to about 12.9×, suggesting the market is pricing in a steep earnings rebound. The stock currently yields 4.97% with a modest forward payout ratio of 9%, but operating cash flow is zero and the company carries a high debt‑to‑equity of 62.9, raising questions about dividend sustainability. Technicals show a bullish MACD crossover, an RSI of 62 indicating momentum, and price sitting near the upper band of its 37.14 support and 46.89 resistance range, while the 30‑day volatility of 39% and beta of 1.6 point to a high‑risk profile. Recent news highlights a record capital‑raising year exceeding $50 billion and a 36% YoY increase in fee‑related earnings, underpinning a forward earnings outlook that could justify the current valuation. Analysts have raised target prices to the mid‑$50s, implying an upside of roughly 20% from the current level of $45.8. However, the company’s negative operating margin (‑31.8%) and a max drawdown of ‑45% over recent periods temper enthusiasm, especially for long‑term holders.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and momentum reflected in RSI above 60
- Upcoming earnings release expected to beat consensus
- Attractive dividend yield relative to peers
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward P/E compression to ~13× indicating earnings growth
- Capital formation strength and 36% fee‑related earnings growth
- Analyst consensus target price around $55 providing ~20% upside
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High valuation multiples and volatile price history
- Sustainable dividend concerns due to zero operating cash flow
- Strong asset‑management franchise with continued capital raising
Key Metrics & Analysis
Financial Health
Revenue Growth-54.80%
Profit Margin4.23%
P/E Ratio99.6
ROE10.76%
ROA3.16%
Debt/Equity62.90
P/B Ratio6.2
Industry P/E17.5
Technical Analysis
TrendNeutral
RSI62.4
Support$37.14
Resistance$46.89
MA 20$42.91
MA 50$41.96
MA 200$54.92
MACDBullish
VolumeStable
Fear & Greed Index90.66
Valuation
Target Price$54.88
Upside/Downside19.78%
GradeFair
TypeBlend
Dividend Yield4.97%
Risk Assessment
Beta1.61
Volatility39.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.